<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(6)</volume><submitter>Sato R</submitter><pubmed_abstract>While prognoses in relation to myocardial infarction (MI) type have been elucidated in past reports, the results were not consistent, perhaps due to occurrence of Type 2 MI with CVS and its mortality. The Japanese registry of acute Myocardial Infarction diagnosed by Universal Definition (J-MINUET) is a prospective multicenter registry in Japan. In contrast to thromboembolic event-related Type 1 myocardial infarction (MI), clinical features of Type 2 MI, including coronary vasospasm (CVS), are varied due to the heterogeneous nature of its development. To elucidate the MI type-related all-cause mortality, 2989 consecutive patients with AMI were stratified as Type 1 MI, Type 2 MI with CVS, and Type 2 MI with non-CVS. Most patients (n = 2834; 94.8%) were classified as Type 1 MI and 155 patient</pubmed_abstract><journal>Journal of clinical medicine</journal><pagination>E1686</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7356040</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Long-Term Prognosis of Patients with Myocardial Infarction Type 1 and Type 2 with and without Involvement of Coronary Vasospasm.</pubmed_title><pmcid>PMC7356040</pmcid><pubmed_authors>Noguchi T</pubmed_authors><pubmed_authors>Okamura A</pubmed_authors><pubmed_authors>Uemura S</pubmed_authors><pubmed_authors>Saito Y</pubmed_authors><pubmed_authors>Mano T</pubmed_authors><pubmed_authors>Ogawa H</pubmed_authors><pubmed_authors>Kaikita K</pubmed_authors><pubmed_authors>Ozaki Y</pubmed_authors><pubmed_authors>Ako J</pubmed_authors><pubmed_authors>Morita Y</pubmed_authors><pubmed_authors>Kimura K</pubmed_authors><pubmed_authors>Nakama Y</pubmed_authors><pubmed_authors>Morita T</pubmed_authors><pubmed_authors>Ohshima S</pubmed_authors><pubmed_authors>Owa M</pubmed_authors><pubmed_authors>Shibata Y</pubmed_authors><pubmed_authors>Yasuda S</pubmed_authors><pubmed_authors>Inoue T</pubmed_authors><pubmed_authors>Kozuma K</pubmed_authors><pubmed_authors>Nishimura K</pubmed_authors><pubmed_authors>Sakamoto K</pubmed_authors><pubmed_authors>Toubaru T</pubmed_authors><pubmed_authors>Saku K</pubmed_authors><pubmed_authors>Nakao K</pubmed_authors><pubmed_authors>Kokubu N</pubmed_authors><pubmed_authors>Fujimoto K</pubmed_authors><pubmed_authors>Hirata K</pubmed_authors><pubmed_authors>Sato R</pubmed_authors><pubmed_authors>Suwa S</pubmed_authors><pubmed_authors>Tanabe K</pubmed_authors><pubmed_authors>Tsujita K</pubmed_authors><pubmed_authors>Shimizu W</pubmed_authors><pubmed_authors>Funayama H</pubmed_authors><pubmed_authors>Ishihara M</pubmed_authors><pubmed_authors>Miyamoto Y</pubmed_authors><pubmed_authors>Hirohata A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Long-Term Prognosis of Patients with Myocardial Infarction Type 1 and Type 2 with and without Involvement of Coronary Vasospasm.</name><description>While prognoses in relation to myocardial infarction (MI) type have been elucidated in past reports, the results were not consistent, perhaps due to occurrence of Type 2 MI with CVS and its mortality. The Japanese registry of acute Myocardial Infarction diagnosed by Universal Definition (J-MINUET) is a prospective multicenter registry in Japan. In contrast to thromboembolic event-related Type 1 myocardial infarction (MI), clinical features of Type 2 MI, including coronary vasospasm (CVS), are varied due to the heterogeneous nature of its development. To elucidate the MI type-related all-cause mortality, 2989 consecutive patients with AMI were stratified as Type 1 MI, Type 2 MI with CVS, and Type 2 MI with non-CVS. Most patients (n = 2834; 94.8%) were classified as Type 1 MI and 155 patient</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jun</publication><modification>2025-04-19T18:00:33.103Z</modification><creation>2025-04-19T18:00:33.103Z</creation></dates><accession>S-EPMC7356040</accession><cross_references><pubmed>32498247</pubmed><doi>10.3390/jcm9061686</doi></cross_references></HashMap>